Point of Care Diagnostic Testing: World Markets

DUBLIN, February 10, 2014 /PRNewswire/ --

Dublin - Research and Markets (http://www.researchandmarkets.com/research/6mzrp4/point_of_care) has announced the addition of the "Point of Care Diagnostic Testing: World Markets" report to their offering. 

Point of care testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather than waiting hours or even days for outside lab results to arrive. Point of care testing covers: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Point of Care Diagnostic Testing World Markets 2013 describes latest developments in the point of care testing market segment. It examines clinical instruments, devices and reagents and supplies as utilized in near-patient environments like hospital emergency rooms, critical care units, clinics and doctor's offices. 

The study defines the dollar volume of point of care sales and makes five year projections both in the U.S. and worldwide - including Europe, Asia and Latin America. It also examines in detail the point of care sector for 25 individual country markets. A detailed summary of all important instruments in each clinical market is provided with emphasis on newly introduced products. 

Key Topics Covered: 

1. Overview 

2. Overview of Diagnostic Testing Point of Care Markets

3. Summary Analysis of the Global POCT Market: Value, Growth Rates and Market Share

4. Analysis of the U.S. POCT Market: Value, Growth Rates and Market Share 

5. Analysis of the European POCT Market: Value, Growth Rates and Market Shares 

6. Analysis of the POCT Markets for Japan, China and India: Value, Growth Rates and Market Share 

7. Analysis of the Rest of World (ROW) POCT Market: Value, Growth Rates and Market Share 

8. Review of the Market Segments, Reagents and Equipment 

9. POCT: Growth Regulators

10. Business Trends in the POC Sector

11. Technology Platform Innovations in POCT

12. Data Management and Connectivity

13. Corporate Profiles

14. POCT Sector Trends and Forecasts

15. New Entrants to the Point of Care Market

Companies Mentioned:

• A Menarini Diagnostics
• ACON Laboratories, Inc
• Abaxis, Inc
• Abbott Laboratories
• AccuBioTech
• AccuTech, LLC
• Accumetrics, Inc
• Acrongenomics
• Aerscher Diagnostics
• AgaMatrix
• Akers Biosciences, Inc
• Alere
• Alfa Scientific Designs, Inc
• Alverix, Inc
• American Bio Medica Corporation
• Analyticon Biotechnologies AG
• Ani Biotech Oy Ltd
• Aptiva Medical, Inc
• ArcDia International Oy Ltd
• Ark Therapeutics
• Arkray, Inc
• Artron Laboratories, Inc
• Atlas
• Atlas Genetics Ltd
• Atlas Link Biotech Co, Ltd
• Atonomics A/S
• Audit Diagnostics
• Augurix Diagnostics Ltd
• Autobio Diagnostics Co, Ltd
• Axis-Shield
• Axxin
• Axxin
• Bayer Corp
• Beckman Coulter
• BiOracle
• Bio-Rad Laboratories, Inc
• BioFire Diagnostics, Inc
• BioHelix Corporation
• BioLytical Laboratories
• BioMedomics
• BioMérieux
• BioScan Screening Systems, Inc
• BioSite
• Biocartis SA
• Biomerica, Inc
• Biosensia Ltd
• Calmark Sweden AB
• Calypte Biomedical Corporation
• Chembio Diagnostic, Inc
• Chempaq A/S
• Cholestech
• Claros Diagnostics
• CompuCyte Corporation
• Concateno Plc
• Curetis AG
• Dexcom
• Diagnostics Chemicals Ltd
• DxNA, LLC
• EY Laboratoires, Inc
• Echo Therapeutics, Inc
• Enigma Diagnostics Ltd
• Eurotrol
• Exalenz Bioscience
• GenBio
• Gentag, Inc
• Genzyme Diagnostics
• Great Basin Corporation
• Guided Therapeutics, Inc (SpectRx, Inc)
• Helena Laboratories
• Hema Diagnostic Systems, LLC
• HemoCue AB
• HemoSense
• Home Diagnostics (Nipro Diagnostics)
• IND Diagnostic
• Immunexpress Group
• Innovative Biosensors, Inc
• Instrumentation Laboratory (IL)/Werfen Group
• Integrated Diagnostics
• Integrity Applications
• International Technidyne Corporation
• Jant Pharmacal Corporation
• Johnson & Johnson
• Lein Applied Diagnostics
• LifeAssays® AB
• LifeSign, LLC
• MBio Diagnostics, Inc
• MELA Sciences (Formerly Electro-Optical Sciences)
• MedMira Laboratories
• Medica
• Medical Automation Systems
• Mediwatch
• Medix Biochemica
• Menssana Research, Inc
• Meretek Diagnostics Group
• Meridian Bioscience
• Metaara Medical Technologies Inc
• Micronics
• Minimed
• Mitsubishi Chemical Holdings USA, Inc
• Mitsubishi Kagaku Iatron
• Nanogen (ELITech Group)
• New Horizons Diagnostics
• Nexus DX/ITC
• Nova Biomedical
• OraSure Technologies, Inc
• Orion Diagnostica
• Polymedco, Inc
• Polymer Technology Systems, Inc
• Prima Biomedical Company
• QBC Diagnostics
• Qualigen
• Quest Diagnostics, Inc
• Quidel Corporation
• Radiometer Medical
• Response Biomedical
• Roche Diagnostics
• Savyon Diagnostics
• Selfcare, Inc
• Shanghai Ruicare Medical
• Shenzhen Fitconn Technology Co, Ltd
• Shionogi & Co, Ltd
• Siemens AG
• Spectral Diagnostics
• StatSure Diagnostic Systems, Inc
• Step Detect Associates
• Strategic Diagnostics
• Trinity Biotech, Plc
• Venaxis, Inc
• Veredus Laboratories Pte Ltd
• Via Medical Corporation
• Vital Diagnostics, Inc
• Vivacta Limited
• Väsamed, Inc Alliance International Co, Ltd
• Wave 80 Biosciences

For more information visit http://www.researchandmarkets.com/research/6mzrp4/point_of_care

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets